Nephrogenic Adenoma of the Urinary Bladder

2005 ◽  
Vol 37 (3) ◽  
pp. 477-481 ◽  
Author(s):  
Konstantinos Zougkas ◽  
Marinos Kalafatis ◽  
Panagiotis Kalafatis
2001 ◽  
Vol 44 (3) ◽  
pp. 377
Author(s):  
Sun Hee Chung ◽  
Sun Wha Lee ◽  
Woon Seupp Han

2020 ◽  
Vol 2020 ◽  
pp. 1-3
Author(s):  
Iftikhar Khan ◽  
Mahmoud Obeid ◽  
Nasreen Hasan ◽  
Fayyad Jaradat ◽  
Bodhisatwa Sengupta ◽  
...  

Nephrogenic adenoma is a rare lesion that consists of epithelial cells arranged in tubular form, resembling tubules in the renal medulla, and is found usually in the urinary bladder although it can occur anywhere in the transitional epithelium of the lower urinary tract. The first case of nephrogenic adenoma of the urinary bladder was reported before the first kidney transplantation, and the lesion has been reported in patients with and without renal transplantation. The origin of cells in nephrogenic adenoma is debated and has been postulated to arise from cells of embryonic origin or from metaplasia secondary to chronic irritation or from implantation of allograft cells in patients with kidney transplantation. The long-term outcome and potential to convert into malignancy are not established, and therefore, there are no recommendations on how to follow up these patients. We present a case of a patient who was found to have nephrogenic adenoma of the urinary bladder during his second kidney transplantation from a cadaveric donor. He had undergone living donor kidney transplantation previously which subsequently failed. The patient did not manifest any symptoms of nephrogenic adenoma. During a follow-up period of 5 years, he has not manifested any symptoms related to nephrogenic metaplasia. Histopathological examination 5 years after the second transplantation did not show any malignant change. It can be concluded that nephrogenic adenoma is likely to behave in benign fashion post kidney transplantation.


1986 ◽  
Vol 10 (6) ◽  
pp. 979-982 ◽  
Author(s):  
A. P. Zingas ◽  
G. A. Kling ◽  
E. Crotte ◽  
E. Shumaker ◽  
P. M. Vazquez

2011 ◽  
Vol 14 (6) ◽  
pp. 438-444 ◽  
Author(s):  
Alison R. Huppmann ◽  
Bruce R. Pawel

Although not uncommon in adults, bladder tumors are rare in children. In addition, the histologic types of tumors seen in the pediatric population differ from those seen in adults. Although rhabdomyosarcoma is the most common pediatric bladder tumor, many other benign, malignant, and reactive lesions can be encountered. All may present clinically as a mass or polyp in the bladder. This study was designed to describe the pathology and patient demographics of pediatric bladder masses, because there are few studies describing these entities. Retrospectively reviewing our experience over a 21-year period, we identified 98 specimens from 65 patients with polyps or masses in the urinary bladder. As expected, the most frequent diagnosis was rhabdomyosarcoma. This was followed by fibroepithelial polyp and a variety of additional nonurothelial tumors. Only 7 urothelial tumors were identified, including 1 low-grade papillary urothelial carcinoma. Inflammatory lesions, such as cystitis cystica and nephrogenic adenoma, were invariably associated with an irritating factor when a history was provided. Our findings emphasize that diagnoses made in the pediatric urinary bladder are distinct from those in adults, although a wide variety of lesions may still be seen.


Urology ◽  
1980 ◽  
Vol 15 (2) ◽  
pp. 190-193 ◽  
Author(s):  
N.V. Raghavaiah ◽  
H. Norman Noe ◽  
David M. Parham ◽  
William M. Murphy

2013 ◽  
Vol 137 (3) ◽  
pp. 371-381 ◽  
Author(s):  
Minghao Zhong ◽  
Elizabeth Gersbach ◽  
Stephen M. Rohan ◽  
Ximing J. Yang

Context.—Glandular lesions of the urinary bladder include a broad spectrum of entities ranging from completely benign glandular lesions to primary and secondary malignancies. Common benign bladder lesions that exhibit glandular differentiation include cystitis cystica, cystitis glandularis, von Brunn nests, nephrogenic adenoma, intestinal metaplasia, urachal remnant, endometriosis, and prostatic-type polyp. The World Health Organization defines primary adenocarcinoma of the bladder as an epithelial malignancy with pure glandular differentiation without evidence of typical urothelial carcinoma. Malignant lesions that should be included in the differential diagnosis of a primary adenocarcinoma of the bladder include noninvasive and invasive urothelial carcinoma with glandular differentiation and secondary malignancies involving the bladder by direct extension or metastasis. The recognition and distinction of these different entities may be a challenge for pathologists, but they are of great clinical importance. Objective.—To review features of primary bladder adenocarcinoma as well as those entities that need to be differentiated from primary bladder adenocarcinoma, with emphasis on clinical findings, pathologic characteristics, and immunoprofiles. Data Sources.—Selected original articles published in the PubMed service of the US National Library of Medicine. Conclusions.—The accurate diagnosis of adenocarcinoma of the urinary bladder is important and challenging. It has to prompt an extensive clinical workup to rule out other glandular lesions in the urinary bladder, especially the possibility of secondary involvement of the bladder by an adenocarcinoma from a different site.


1981 ◽  
Vol 12 (10) ◽  
pp. 907-916 ◽  
Author(s):  
Belur S. Bhagavan ◽  
Esperanza M. Tiamson ◽  
Robert E. Wenk ◽  
Bruce W. Berger ◽  
Gary Hamamoto ◽  
...  

1974 ◽  
Vol 46 (1) ◽  
pp. 97-99 ◽  
Author(s):  
O. P. TANEJA ◽  
A. L. AURORA ◽  
N. K. GROVER ◽  
S. M. GULATI ◽  
N. K. TAGORE

Sign in / Sign up

Export Citation Format

Share Document